Norton Healthcare shared a post on LinkedIn:
“Gynecologic cancers are often rare and complex, making access to specialized trials essential. Norton Cancer Institute is strengthening that access with a rapidly expanding research portfolio and a dedicated team of gynecologic oncologists driving early-phase innovation.
From immunotherapy studies to trials exploring prevention and early-detection strategies, this program is creating new opportunities for patients who previously faced major barriers to specialty care.
Read the full article to see how this growth is reshaping care and clinical trial access.”
David O’Malley, Professor and Division Director of Gynecologic Oncology, Co-Director, The Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute, shared a post by Norton Healthcare, adding:
“So amazing to see Monica Hagan Vetter– a graduate of the Gyn Oncology Fellowship at The Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute – and the Norton Healthcare Gyn Oncology team leading the way in clinical research.”